Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Chondro-Gide®Clinical Study of Chondro-Gide® for Large Chondral Lesions in the Knee

Sponsor:

Geistlich Pharma AG

Code:

NCT04537013

Conditions

Knee Injuries

Cartilage Injury

Cartilage Disease

Knee Discomfort

Eligibility Criteria

Sex: All

Age: 18 - 55

Healthy Volunteers: Not accepted

Interventions

Microfracture

Microfracture plus placement of Chondro-Gide® ACC

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-06-16. This information was provided to ClinicalTrials.gov by Geistlich Pharma AG on 2025-05-04.